Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HEMOPHILIA B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04590950
What this trial is testing

Dosage and PD Study of Eftrenonacog-alfa

Who this might be right for
Severe Haemophilia B
Assistance Publique - Hôpitaux de Paris 15
Very early researchUnknownNCT06119659
What this trial is testing

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Who this might be right for
Hemophilia B Without Inhibitor
Zhejiang University 9
Not applicableNot Yet RecruitingNCT07421154
What this trial is testing

Study of a Smart Sharps Disposal Device in Patients With Hemophilia

Who this might be right for
Hemophilia A and B
University of Pennsylvania 23
Very early researchUnknownNCT05152732
What this trial is testing

Safety and Tolerability of VGB-R04 in Patients With Haemophilia B

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 3
Testing effectiveness (Phase 2)Ended earlyNCT04394286
What this trial is testing

SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects

Who this might be right for
Hemophilia B
Baxalta now part of Shire 2
Not applicableStudy completedNCT00244114
What this trial is testing

Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT03363321
What this trial is testing

PF-06741086 Long-term Treatment in Severe Hemophilia

Who this might be right for
Hemophilia A or B
Pfizer 20
Post-approval studies (Phase 4)Study completedNCT00571584
What this trial is testing

High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 24
Large-scale testing (Phase 3)Study completedNCT01440946
What this trial is testing

Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B

Who this might be right for
Hemophilia B
Bioverativ Therapeutics Inc. 30
Large-scale testing (Phase 3)Study completedNCT03855280
What this trial is testing

Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B

Who this might be right for
Hemophilia B
Medexus Pharma, Inc. 21
Post-approval studies (Phase 4)Ended earlyNCT05856266
What this trial is testing

An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa

Who this might be right for
Hemophilia AHemophilia B
Swedish Orphan Biovitrum 10
Testing effectiveness (Phase 2)Study completedNCT02396342
What this trial is testing

Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 10
Very early researchStudy completedNCT04789954
What this trial is testing

Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
AryoGen Pharmed Co. 14
Large-scale testing (Phase 3)Study completedNCT00543439
What this trial is testing

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Who this might be right for
Hemophilia A
Pfizer 66
Large-scale testing (Phase 3)Study completedNCT01286779
What this trial is testing

BAX 326 (rFIX) Continuation Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 117
Not applicableStudy completedNCT04272554
What this trial is testing

AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)

Who this might be right for
Hemophilia BBlood Coagulation Disorders, InheritedBlood Coagulation Disorder+1 more
Spur Therapeutics 37
Not applicableEnded earlyNCT02392156
What this trial is testing

Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes

Who this might be right for
Hemophilia AHemophilia B
Bioverativ Therapeutics Inc. 3
Large-scale testing (Phase 3)Study completedNCT01757405
What this trial is testing

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 40
Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Not applicableUnknownNCT06158334
What this trial is testing

Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®)

Who this might be right for
Hemophilia AHemophilia B
Hospices Civils de Lyon 400
Next Page